![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0359.png)
Page
32
of
76
positives following the USDA/FSIS-MLG 5B.05 reference method
confirmation procedure. There were 13 observed positives for the
reference method. For the high inoculation level, there were 5
presumptive positives and 5 confirmed positives following the
USDA/FSIS-MLG 5B.05 reference method confirmation procedure. There
were 5 confirmed positives following the reference method.
For the low inoculation level, a dPOD
C
value of 0.00 was obtained with a
95% confidence interval of (-0.28, 0.28), indicating no significant
difference between the candidate and reference methods. A dPOD
CP
value of 0.00 was obtained with a 95% confidence interval of (-0.28,
0.28), indicating no significant difference between the candidate
presumptive and confirmed results.
For the high inoculation level, a dPOD
C
value of 0.00 was obtained with a
95% confidence interval of (-0.43, 0.43), indicating no significant
difference between the candidate and reference methods. A dPOD
CP
value of 0.00 was obtained with a 95% confidence interval of (-0.43,
0.43), indicating no significant difference between the candidate
presumptive and confirmed results. Detailed results of the POD analyses
are presented in Tables 16 and 20 of the Appendix.
Robustness Evaluation
When changing the operational parameters of the enrichment incubation time,there
was an observed effect on the results. For the 8 hour incubation, both assays failed
to detect the target analyte. For the 9 hour incubation time, the Screen Plus
Pathogen Detection Assay had no observed effect on the results but the STEC O-
Type Pathogen Detection Assay produced two discrepant results when compared to
the Screen Plus Pathogen Detection
Assay.Atthe 10 hour time point, modification to
the lysis heat time, and PCR Master Mix to DNA sample volume caused no
observed discrepancies.
mericonE. coli O157 Screen Plus Pathogen Detection Assay
Treatment Combination 1
For treatment combination 1, there was 1 presumptive positive out of 10 replicates
for the variations evaluated. For the 5 uninoculatedtest portions, there were 0
presumptive positives out of 5 replicates.
For the low inoculation level, a POD value of 0.10 was obtained with a 95%
confidence interval of (0.00, 0.42). All 5 uninoculated test portions were negative
with a POD value of 0.00 with a 95% confidence interval of (0.00, 0.43).
Treatment Combination 2
For treatment combination 2, there were 4 presumptive positives out of 10 replicates
for the variations evaluated. For the 5 uninoculated test portions, there were 0
presumptive positives out of 5 replicates.
OMAMAN-36 E/ AOAC PTM Report
ERP Use Only
January 2017
AOAC Research Institute
Expert Review Panel Use Only